103 related articles for article (PubMed ID: 9673960)
1. Water medication of a swine herd with amoxycillin.
Agersø H; Friis C; Haugegaard J
J Vet Pharmacol Ther; 1998 Jun; 21(3):199-202. PubMed ID: 9673960
[TBL] [Abstract][Full Text] [Related]
2. PK and PK/PD of doxycycline in drinking water after therapeutic use in pigs.
Prats C; El Korchi G; Giralt M; Cristòfol C; Peña J; Zorrilla I; Saborit J; Pérez B
J Vet Pharmacol Ther; 2005 Dec; 28(6):525-30. PubMed ID: 16343284
[TBL] [Abstract][Full Text] [Related]
3. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media.
Dorey L; Hobson S; Lees P
Res Vet Sci; 2017 Apr; 111():43-48. PubMed ID: 27940285
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Salmonella choleraesuis isolates from pigs.
Raemdonck DL; Tanner AC; Tolling ST; Michener SL
Vet Rec; 1994 Jan; 134(1):5-7. PubMed ID: 8128570
[TBL] [Abstract][Full Text] [Related]
5. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
Dorey L; Pelligand L; Lees P
BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
Dorey L; Pelligand L; Cheng Z; Lees P
PLoS One; 2017; 12(5):e0177568. PubMed ID: 28552968
[TBL] [Abstract][Full Text] [Related]
7. Penetration of amoxycillin to the respiratory tract tissues and secretions in Actinobacillus pleuropneumoniae infected pigs.
Agersø H; Friis C; Nielsen JP
Res Vet Sci; 1998; 64(3):251-7. PubMed ID: 9690612
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae.
Rose M; Menge M; Bohland C; Zschiesche E; Wilhelm C; Kilp S; Metz W; Allan M; Röpke R; Nürnberger M
J Vet Pharmacol Ther; 2013 Apr; 36(2):140-53. PubMed ID: 22500881
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
Dorey L; Pelligand L; Cheng Z; Lees P
J Vet Pharmacol Ther; 2017 Oct; 40(5):505-516. PubMed ID: 28090673
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of doxycycline and oxytetracycline against porcine respiratory pathogens.
Bousquet E; Morvan H; Aitken I; Morgan JH
Vet Rec; 1997 Jul; 141(2):37-40. PubMed ID: 9253829
[TBL] [Abstract][Full Text] [Related]
11. Activity of florfenicol for Actinobacillus pleuropneumoniae and Pasteurella multocida using standardised versus non-standardised methodology.
Dorey L; Hobson S; Lees P
Vet J; 2016 Dec; 218():65-70. PubMed ID: 27938711
[TBL] [Abstract][Full Text] [Related]
12. The pharmacodynamic effect of amoxycillin and danofloxacin against Actinobacillus pleuropneumoniae in an in-vitro pharmacodynamic model.
Lindecrona RH; Friis C; Jensen NE
Res Vet Sci; 1999 Aug; 67(1):93-7. PubMed ID: 10425247
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
Dorey L; Hobson S; Lees P
Res Vet Sci; 2017 Apr; 111():93-98. PubMed ID: 28113129
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
Dayao D; Gibson JS; Blackall PJ; Turni C
Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
[TBL] [Abstract][Full Text] [Related]
15. Tilmicosin enteric granules and premix to pigs: Antimicrobial susceptibility testing and comparative pharmacokinetics.
Xiong J; Zhu Q; Zhao Y; Yang S; Cao J; Qiu Y
J Vet Pharmacol Ther; 2019 May; 42(3):336-345. PubMed ID: 30801755
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a single dose versus a divided dose regimen of amoxycillin in treatment of Actinobacillus pleuropneumoniae infection in pigs.
Lauritzen B; Lykkesfeldt J; Friis C
Res Vet Sci; 2005 Aug; 79(1):61-7. PubMed ID: 15894026
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine.
Inamoto T; Kikuchi K; Iijima H; Kawashima Y; Nakai Y; Ogimoto K
J Vet Med Sci; 1994 Oct; 56(5):917-21. PubMed ID: 7865594
[TBL] [Abstract][Full Text] [Related]
18. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs.
Blackall PJ; Asakawa T; Graydon RJ; White M; Adamson M; Wade LK; Lowe LB
Aust Vet J; 1995 Jan; 72(1):35-6. PubMed ID: 8787526
[No Abstract] [Full Text] [Related]
19. In-vitro activities of penicillin, amoxycillin and certain cephalosporins, including cefpodoxime, against human isolates of Pasteurella multocida.
Avril JL; Mesnard R; Donnio PY
J Antimicrob Chemother; 1991 Sep; 28(3):473-4. PubMed ID: 1960130
[No Abstract] [Full Text] [Related]
20. Sensitivity of A pleuropneumoniae and P multocida to ceftiofur.
Hewett GR
Vet Rec; 1994 Feb; 134(8):200. PubMed ID: 8171805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
